glp 1 news today Eli Lilly to seek approval of new GLP-1 weight-loss drug this year Eli Lilly CEO launches Medicare
Description
Poor food choices during GLP-1 therapy create a predictable set of problems
Wegovy has been clinically studied for weight management
MyPlate Participants completed a questionnaire self-reporting their typical daily servings from each food group (based on MyPlate) since beginning GLP-1RA
These effects go beyond weight loss to address broader health risks
Many people treated with these medications will have gastrointestinal side effects like nausea and constipation, and these often abate over time
